Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| LARIMAR THERAPEUTICS | 9 | 4 | +2,65 % | ||
| TAYSHA GENE THERAPIES | 8 | - | +2,47 % | ||
| COLLEGIUM PHARMACEUTICAL | 7 | 1 | +2,63 % | ||
| HUMACYTE | 6 | 4 | 0,00 % | ||
| SAREPTA THERAPEUTICS | 5 | 1 | -3,15 % | ||
| BIONTECH | 4 | 13 | -1,53 % | ||
| ETON PHARMACEUTICALS | 4 | 5 | +8,74 % | ||
| VIATRIS | 4 | 2 | -3,05 % | ||
| ALUMIS | 4 | 2 | -0,08 % | ||
| THERAVANCE BIOPHARMA | 4 | - | 0,00 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Jefferies reiterates Collegium Pharmaceutical stock Buy on ADHD deal | 1 | Investing.com | ||
| Do | Truist reiterates Buy on Scholar Rock stock after Roche halts rival drug | 3 | Investing.com | ||
| Do | Rhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE (setmelanotide) for Patients with Acquired Hypothalamic Obesity | 1 | GlobeNewswire (USA) | ||
| Do | Taysha outlines 2026 BLA submission path for TSHA-102 as pivotal trial enrollment advances | 1 | Seeking Alpha | ||
| Do | BMO reiterates Scholar Rock stock rating on rival drug discontinuation | 2 | Investing.com | ||
| Do | Theravance Biopharma stock rating reiterated at Buy by BTIG on revenue beat | 1 | Investing.com | ||
| Do | Jefferies raises Taysha Gene Therapies price target on trial progress | 2 | Investing.com | ||
| Do | COLLEGIUM PHARMACEUTICAL, INC - 8-K, Current Report | 1 | SEC Filings | ||
| Do | Larimar Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| Do | Solid Biosciences GAAP EPS of -$0.53 misses by $0.02 | 1 | Seeking Alpha | ||
| Do | Alumis reports FY results | 1 | Seeking Alpha | ||
| Do | Eton Pharmaceuticals: EPS übertrifft Schätzungen um 0,01 $ - Umsatz schlechter als erwartet | 7 | Investing.com Deutsch | ||
| Do | ALUMIS INC. - 10-K, Annual Report | 1 | SEC Filings | ||
| Do | Solid Biosciences Inc.: Solid Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates | 2 | GlobeNewswire (USA) | ||
| Do | Eton Pharmaceuticals, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| Do | Eton Pharmaceuticals, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| Do | ALUMIS INC. - 8-K, Current Report | 1 | SEC Filings | ||
| Do | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) | 2 | GlobeNewswire (USA) | ||
| Do | Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results | 2 | GlobeNewswire (USA) | ||
| Do | Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results | 1 | GlobeNewswire (USA) |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.